Background: Two patients with bilateral Mooren-type ulcers had underly
ing chronic hepatitis C virus (HCV) infection. Both patients also had
chronic, pruritic dermatitis, which in one patient was diagnosed as hi
dradentitis suppurativa.Methods: Serum from the first patient and seru
m, conjunctiva, and liver from the second patient were analyzed for HC
V genomic RNA using the reverse transcriptase-polymerase chain reactio
n. Serum anti-HCV antibodies were monitored with a commercially availa
ble second-generation test. Liver and conjunctival biopsies were evalu
ated histopathologically. Results: Liver biopsy showed severe hepatiti
s in the first patient, but normal liver tissue in the second. Hepatit
is C virus genomic RNA was detected in the serum of both patients. In
the first patient, the virus was detected 4 months after completion of
interferon alfa-2b treatment for chronic active hepatitis. In the sec
ond patient, HCV genomic RNA was detected in serum, but not in conjunc
tiva or liver tissue. Hepatitis C virus could not be detected in the s
erum of the second patient after 2 weeks of interferon alfa-2b treatme
nt. Both patients had serum anti-HCV antibodies. In case 1, there was
a marked improvement in the corneal disease during and after 6 months
of interferon alfa-2b treatment for chronic active hepatitis that para
lleled a return of serum liver enzyme levels to the normal range. In t
he second patient, the corneal disease improved after 6 weeks of inter
feron alfa-2b treatment, but abruptly worsened when the patient discon
tinued therapy. The corneal disease improved again after interferon al
fa-2b was reinstituted. Conclusions: Chronic HCV virus infection is as
sociated with Mooren-type peripheral ulcerative keratitis. All patient
s with Mooren-type ulcers should be tested for evidence of HCV infecti
on in consultation with a liver specialist. Even when improvement is o
btained with interferon alfa-2b treatment, however, continued follow-u
p is important because relapse is common and repeat treatment may be e
ffective.